Renaissance Technologies - AMNEAL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$482
+217.1%
114,100
+49.3%
0.00%
Q4 2022$152
-99.9%
76,400
-46.2%
0.00%
Q3 2022$287,000
-47.6%
141,900
-17.7%
0.00%
-100.0%
Q2 2022$548,000
+91.6%
172,400
+151.3%
0.00%
Q1 2022$286,000
-90.5%
68,600
-84.7%
0.00%
-100.0%
Q1 2021$3,019,000
+282.6%
448,660
+160.0%
0.00%
+300.0%
Q4 2020$789,000
+53.5%
172,549
+140.7%
0.00%
Q2 2019$514,000
-90.6%
71,700
-81.5%
0.00%
-100.0%
Q1 2019$5,489,000
-57.5%
387,400
-59.4%
0.01%
-64.3%
Q4 2018$12,904,000
+52.7%
953,700
+150.5%
0.01%
+55.6%
Q3 2018$8,448,000380,7000.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders